SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193805-20-000049
Filing Date
2020-01-17
Accepted
2020-01-17 16:05:13
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT IV, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD PRIVATE DESIGN FUND IV, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e619292_sc13da-artara.htm SC 13D/A 171700
  Complete submission text file 0001193805-20-000049.txt   173430
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13D/A

Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88372 | Film No.: 20533599
SIC: 2836 Biological Products, (No Diagnostic Substances)